NEXTURNBIOSCIENCE Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 96.18 million compared to KRW 32.97 million a year ago. Net loss was KRW 2,747.73 million compared to KRW 1,508.38 million a year ago.
For the nine months, sales was KRW 158.48 million compared to KRW 90.68 million a year ago. Net income was KRW 547.54 million compared to net loss of KRW 5,899.96 million a year ago.